On behalf of the Editorial Board and publisher it is my pleasure to cordially invite you to contribute your work to the Clinical Medicine: Oncology (CMO) published by Libertas Academica. The journal covers a broad area in the field of oncology. This open access journal facilitates rapid publication with immediate world wide exposure.

With outstanding Managing Editor and staff, as well as a well-developed web-based interface, publication in CMO is straightforward. All submissions are peer reviewed and processed in a timely manner. Attempting to accelerate an efficient peer review of manuscripts and decision making processes, we strive to make a final decision within two weeks for 90% of the submitted papers and this would be rather advantageous to publish earlier in the competitive reality.

The journal offers an authoritative and rapid review by international experts in the field, and is designed for rapid, free and unlimited dissemination of knowledge to readers around the world. As the Editor-in-Chief, I can assure you of impartial, rigorous and speedy review of all manuscripts submitted in the area of oncology. Publishing in CMO is a great opportunity to bring your work to the broad scientific and clinical communities.

I look forward to working with you and seeing your published work in our journal!

What is the advantage to you of publishing in Clinical Medicine: Oncology?

Full open access: everyone can read your article and you retain copyright in it
Publishing decision within 2 weeks of submission
Your paper will not be rejected due to lack of space and will be published immediately on acceptance
Prompt and fair peer review from two expert peer reviewers
Frequent updates on your paper’s status
Friendly responsive staff

What a previous author said:

"The publishing process of this journal was a most pleasant and productive experience. I was particularly impressed with the regular updates of the progress of my submission. Many other journals receive a submission and authors may not hear anything for months. I appreciate your notification policy."

In summary:

The advantages of a younger journal such as Clinical Medicine: Oncology are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.

Timing and deadlines:

Submissions are welcomed at any time. Papers are published on an on-going basis.

Next steps:

** Click on the link for further information **

Yours sincerely,

Dr William CS Cho

Editor-in-Chief
Clinical Medicine: Oncology